Trinity Capital Inc. Expands Life Sciences Operations with Appointment of Joshua Ruben as Managing Director

Rhea-AI Summary

Trinity Capital Inc. (NASDAQ: TRIN) has appointed Joshua Ruben as Managing Director of Life Sciences. Ruben brings over a decade of investment banking experience, having completed transactions worth over $50 billion in M&A and capital raises. Previously, he was Head of Life Science Tools and Diagnostics coverage at RBC Capital Markets and helped establish the Corporate Finance Advisory Group at Wells Fargo.

Rob Lake, Senior Managing Director of Life Sciences at Trinity, expressed confidence that Ruben's experience and industry connections will be valuable as the company grows its portfolio and invests in innovative companies. Ruben, based in Phoenix, AZ, is a published expert in corporate finance and a former teaching fellow of economics at Harvard College. He holds degrees from Pomona College and Harvard Business School.

Positive

• Appointment of experienced Managing Director for Life Sciences division
• New hire brings over $50 billion in transaction experience
• Potential for expanded network and industry connections
• Expertise in M&A and capital raises for life science companies

Negative

• None.

PHOENIX, July 22, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the appointment of Josh Ruben as Managing Director of Life Sciences. Mr. Ruben, an established leader with over a decade of experience in investment banking, has a long track record of supporting life science companies with over $50 billion of transactions completed across M&A and capital raises. He is based in Phoenix, AZ.

"We are delighted to welcome Josh to our team," said Rob Lake, Senior Managing Director, Life Sciences of Trinity. "We believe his experience and his vast network of industry connections will prove to be invaluable as we continue to grow our portfolio and invest in innovative companies."

Mr. Ruben joins Trinity after 12 years in the investing banking sector, most recently at RBC Capital Markets where he was Head of Life Science Tools and Diagnostics coverage. Prior to that, he helped establish the Corporate Finance Advisory Group at Wells Fargo. He is a published expert in corporate finance and a former teaching fellow of economics at Harvard College. He holds degrees from Pomona College and Harvard Business School.

"I am thrilled to join the team at Trinity and eager to support groundbreaking companies within the life science sector," said Mr. Ruben. "Trinity has a stellar reputation, and I look forward to leveraging my expertise to drive innovation and growth."

About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience and track record in lending to growth stage companies. For more information, please visit the Company's website at www.trinitycap.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-expands-life-sciences-operations-with-appointment-of-joshua-ruben-as-managing-director-302202179.html

SOURCE Trinity Capital Inc.

FAQ

Who is Joshua Ruben and what is his new role at Trinity Capital Inc. (TRIN)?

Joshua Ruben has been appointed as Managing Director of Life Sciences at Trinity Capital Inc. (NASDAQ: TRIN). He brings over a decade of investment banking experience and has completed transactions worth over $50 billion in M&A and capital raises.

What is Joshua Ruben's professional background before joining Trinity Capital (TRIN)?

Before joining Trinity Capital, Joshua Ruben spent 12 years in investment banking. He was most recently the Head of Life Science Tools and Diagnostics coverage at RBC Capital Markets and previously helped establish the Corporate Finance Advisory Group at Wells Fargo.

How might Joshua Ruben's appointment impact Trinity Capital's (TRIN) life sciences operations?

Joshua Ruben's appointment is expected to strengthen Trinity Capital's life sciences operations. His extensive experience, industry connections, and expertise in M&A and capital raises could help Trinity grow its portfolio and invest in innovative companies within the life science sector.

What are Joshua Ruben's educational qualifications mentioned in the Trinity Capital (TRIN) press release?

According to the press release, Joshua Ruben holds degrees from Pomona College and Harvard Business School. He is also a former teaching fellow of economics at Harvard College.